おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
TranS1
company
About
TranS1 develops a portfolio of medical products and intellectual property in the area of advanced surgical medicine.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $12M
- Industries
- Biotechnology,Health Care,Life Science,Manufacturing,Medical Device,mHealth
- Founded date
- Jan 1, 2002
- Number Of Employee
- 101 - 250
- Operating Status
- Active
TranS1 develops a portfolio of medical products and intellectual property in the area of advanced surgical medicine. It began operation in 2002.TranS1 has its headquarters in Denver in Colorado. It operates as a subsidiary of The Quandary Group.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$12M
TranS1 has raised a total of
$12M
in funding over 2 rounds. Their latest funding was raised on
May 12, 2003 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2003 | Series B | $12M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
TranS1 is funded by 2 investors.
Sapient Capital Partners
and Cutlass Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Sapient Capital Partners
|
— | Series B |
Cutlass Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
